| Roy, Hemant K. |
Baylor College Of Medicine
United States |
Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications |
5R01CA224911-05 |
Matthew Young, Ph.D. |
| Rozengurt, Juan Enrique |
University Of California Los Angeles
United States |
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression |
5R21CA258125-02 |
Gabriela Riscuta, M.D., CNS |
| Russell, John A |
University Of Wisconsin-Madison
United States |
Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment |
5R37CA225608-07 |
Cecilia Lee, Dr.P.H., RN |
| Saenger, Yvonne Margaret |
Albert Einstein College Of Medicine
United States |
Applying pathomics to establish a biosignature for aggressive skin melanoma |
5R01CA260375-04 |
Guillermo Marquez, Ph.D. |
| Salami, Simpa Samuel |
University Of Michigan At Ann Arbor
United States |
Defining the Biological Arc of Grade Group 1 Prostate Cancer |
5R37CA283857-02 |
Guillermo Marquez, Ph.D. |
| Salman, Emad |
Florida Assn Of Pediatric Tumor Prog
United States |
The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program. |
5UG1CA189973-11 |
Vanessa A. White, M.P.H. |
| Salvemini, Daniela |
Saint Louis University
United States |
A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity |
5R01CA230512-05 |
Rachel Altshuler, Ph.D. |
| Salvemini, Daniela |
Saint Louis University
United States |
Fingolimod and Ozanimod for the treatment and prevention of chemobrain |
5R01CA261979-03 |
Rachel Altshuler, Ph.D. |
| Sanchez, Eduardo Vilar |
University Of Tx Md Anderson Can Ctr
United States |
Cancer Immune-Interception for Lynch Syndrome |
5R01CA257375-04 |
Asad Umar, D.V.M., Ph.D. |
| Sanchez, Eduardo Vilar |
University Of Tx Md Anderson Can Ctr
United States |
Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome |
5R01CA260761-03 |
Asad Umar, D.V.M., Ph.D. |